Bruce G. Allen Investments’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$506K Buy
3,934
+48
+1% +$5.62K 0.32% 38
2026
Q1
$467K Sell
3,886
-272
-7% -$31.4K 0.31% 42
2025
Q4
$438K Buy
4,158
+291
+8% +$27.3K 0.3% 40
2025
Q3
$325K Sell
3,867
-12
-0.3% -$988 0.23% 50
2025
Q2
$307K Buy
3,879
+651
+20% +$51.7K 0.23% 51
2025
Q1
$290K Buy
3,228
+65
+2% +$6.07K 0.23% 50
2024
Q4
$315K Buy
3,163
+27
+0.9% +$2.78K 0.26% 51
2024
Q3
$356K Sell
3,136
-118
-4% -$14K 0.28% 48
2024
Q2
$403K Sell
3,254
-670
-17% -$86.3K 0.34% 42
2024
Q1
$518K Buy
3,924
+37
+1% +$4.56K 0.43% 34
2023
Q4
$424K Buy
+3,887
New +$403K 0.39% 38

Other funds holding MRK

Bruce G. Allen Investments's MRK Position: Q2 2026 in Review

Bruce G. Allen Investments increased its Merck (MRK) stake by 1.2% in Q2 2026, buying an estimated $5.62K and bringing the position to 3,934 shares worth $506K. The position accounts for 0.32% of the portfolio, ranked #38.

Bruce G. Allen Investments first reported a position in MRK in Q4 2023 and has held it in 11 quarters since. The position peaked at $518K in Q1 2024. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Bruce G. Allen Investments held 3,934 shares of Merck worth $506K as of Q2 2026.
  • Bruce G. Allen Investments bought 48 Merck shares in Q2 2026, an estimated $5.62K.
  • Merck made up 0.32% of Bruce G. Allen Investments's portfolio in Q2 2026, its #38 holding.
  • Bruce G. Allen Investments first reported a position in Merck in Q4 2023 and has held it in 11 quarters since.
  • Bruce G. Allen Investments's Merck position peaked at $518K in Q1 2024.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Bruce G. Allen Investments's 13F filing for Q2 2026, filed 31 Jul 2026.